Muhammad Usman, Shabbir Ahmad, Muhammad Sibt-e-Abbas, Rizwan Ullah, Rimsha Umar

NUTRACEUTICALS: A WAY FORWARD FOR CANCER TREATMENT

Introduction

Nutraceuticals: a way forward for cancer treatment. Explore nutraceuticals as a promising, cost-effective alternative for cancer treatment. Discover natural compounds offering therapeutic potential with minimal side effects, complementing standard care.

Abstract

Background: Cancer is a term used for large groups of diseases that are characterized by gene malfunction and cause abnormal cell proliferation that affects different parts of the human body. There are different traditional treatments of cancer, such as radiation and chemotherapy, but they often have significant side effects. Objectives: This review article aims to describe various types of cancer, their treatments, and associated problems. All the treatment methods for cancer are costly. However, the use of nutraceuticals for cancer treatment is cheap. Methodology: Research papers on the therapeutic benefits of nutraceuticals against cancer were collected from various electronic databases, including Google Scholar, PubMed, and Science Direct. The research papers from 2000 to 2024 were collected and analyzed. Results: There are different sources of nutraceuticals, such as animal, plant, and microbial origins. They exhibit antioxidant, anti-cancer and anti-inflammatory effects by enhancing the immune system and inhibiting metastasis. For example, a compound beta-sitosterol derived from plants is very effective against cancer of different body parts. Similarly, sulforaphane present in cruciferous vegetables is very effective in reducing the risk of lung cancer. Additionally, curcumin from turmeric is effective in inhibiting metastatic cancer cells. Conclusion: In recent years, there has been a growing focus on the use of nutraceuticals in cancer treatment. This approach offers promising therapeutic potential with minimal or no side effects, making it a safer alternative to conventional therapies. Nutraceuticals are increasingly being integrated into comprehensive cancer care, complementing standard treatments and enhancing patient outcomes.

Review

This review article, titled "NUTRACEUTICALS: A WAY FORWARD FOR CANCER TREATMENT," addresses a highly relevant and pressing issue in modern healthcare: the limitations of traditional cancer therapies and the potential for alternative approaches. The authors aim to provide a comprehensive overview of cancer types, conventional treatments, and their associated challenges, while positioning nutraceuticals as a cost-effective and safer therapeutic option. The methodology, involving a broad search of electronic databases for papers published between 2000 and 2024, suggests a contemporary and reasonably thorough exploration of the existing literature on the therapeutic benefits of nutraceuticals against cancer. The abstract effectively highlights the key findings and the purported mechanisms of action of various nutraceuticals. It categorizes nutraceuticals by origin (animal, plant, microbial) and outlines their benefits, including antioxidant, anti-cancer, and anti-inflammatory effects, alongside immune system enhancement and inhibition of metastasis. Specific examples like beta-sitosterol, sulforaphane, and curcumin are cited for their efficacy against various cancers and metastatic cells, lending concrete support to the central premise. The conclusion posits that nutraceuticals offer promising potential with minimal side effects, making them a safer complement to conventional therapies and a valuable component of integrated cancer care. While the abstract presents a compelling and optimistic outlook on nutraceuticals in oncology, an expert review would also critically examine the depth of evidence presented. The assertion of "minimal or no side effects" and being a "safer alternative" requires careful substantiation, particularly concerning potential interactions with conventional therapies and long-term effects in human clinical settings. To truly chart "a way forward," the full review would benefit from a more nuanced discussion of the challenges inherent in nutraceutical research and application, such as issues of bioavailability, standardization, optimal dosage, regulatory hurdles, and the imperative for more extensive, high-quality human clinical trials to validate the promising *in vitro* and *in vivo* findings. This would provide a more balanced perspective, acknowledging both the considerable promise and the significant work still required for these compounds to become widely accepted and integrated primary treatments in comprehensive cancer care.

Full Text

Comments

You need to be logged in to post a comment.